Arcadia Investment Management Corp Bristol Myers Squibb CO Transaction History

Arcadia Investment Management Corp

$645 Million
Q3 2025

A detailed history of Arcadia Investment Management Corp transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Arcadia Investment Management Corp holds 27,414 shares of BMY stock, worth $1.28 Million. This represents 0.19% of its overall portfolio holdings.

Number of Shares

27,414

Previous 23,939 14.52%

Holding current value

$1.28 Million

Previous $1.11 Million 11.55%

% of portfolio

0.19%

Previous 0.18%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Oct 27, 2025	BUY	$43.31 - $48.98 $150,502 - $170,205	3,475 Added 14.52%	27,414 $1.24 Million
Q2 2025 Aug 08, 2025	SELL	$44.12 - $59.6 $39,134 - $52,865	-887 Reduced 3.57%	23,939 $1.11 Million
Q1 2025 Apr 30, 2025	SELL	$53.9 - $63.11 $9,432 - $11,044	-175 Reduced 0.7%	24,826 $1.51 Million
Q3 2024 Oct 29, 2024	BUY	$39.66 - $51.75 $17,053 - $22,252	430 Added 1.75%	25,001 $1.29 Million
Q2 2024 Aug 05, 2024	BUY	$40.25 - $52.99 $647,220 - $852,079	16,080 Added 189.38%	24,571 $1.02 Million

Q1 2024 Apr 23, 2024	SELL	$47.98 - $54.4 $1.47 Million - $1.67 Million	-30,637 Reduced 78.3%	8,491 $460,000
Q4 2023 Feb 07, 2024	SELL	$48.48 - $57.85 $3.43 Million - $4.09 Million	-70,782 Reduced 64.4%	39,128 $2.01 Million
Q3 2023 Oct 23, 2023	BUY	$57.89 - $64.73 $60,958 - $68,160	1,053 Added 0.97%	109,910 $6.38 Million
Q2 2023 Jul 24, 2023	SELL	$63.71 - $70.74 $174,119 - $193,332	-2,733 Reduced 2.45%	108,857 $6.96 Million
Q1 2023 May 05, 2023	BUY	$65.71 - $74.53 $689,297 - $781,819	10,490 Added 10.38%	111,590 $7.73 Million
Q4 2022 Feb 08, 2023	SELL	$68.48 - $81.09 $1.31 Million - $1.55 Million	-19,170 Reduced 15.94%	101,100 $7.27 Million
Q3 2022 Oct 19, 2022	SELL	$0.13 - $76.84 $186 - $110,034	-1,432 Reduced 1.18%	120,270 $8.55 Million
Q2 2022 Jul 21, 2022	BUY	$72.62 - $79.98 $228,898 - $252,096	3,152 Added 2.66%	121,702 $9.37 Million
Q1 2022 Apr 28, 2022	SELL	$61.48 - $73.72 $897,915 - $1.08 Million	-14,605 Reduced 10.97%	118,550 $8.66 Million
Q4 2021 Feb 09, 2022	SELL	$53.63 - $62.52 $340,604 - $397,064	-6,351 Reduced 4.55%	133,155 $8.3 Million
Q3 2021 Nov 10, 2021	BUY	$59.17 - $69.31 $24,378 - $28,555	412 Added 0.3%	139,506 $8.26 Million
Q2 2021 Aug 02, 2021	BUY	$61.91 - $67.42 $395,047 - $430,207	6,381 Added 4.81%	139,094 $9.29 Million
Q1 2021 Apr 30, 2021	BUY	$59.34 - $66.74 $1.93 Million - $2.17 Million	32,472 Added 32.39%	132,713 $8.38 Million
Q4 2020 Feb 11, 2021	BUY	$57.74 - $65.43 $616,951 - $699,119	10,685 Added 11.93%	100,241 $6.22 Million
Q3 2020 Nov 12, 2020	BUY	$57.43 - $63.64 $367,379 - $407,105	6,397 Added 7.69%	89,556 $5.4 Million
Q1 2020 May 13, 2020	BUY	$46.4 - $67.43 $3.81 Million - $5.54 Million	82,159 Added 8215.9%	83,159 $4.64 Million
Q3 2017 Oct 18, 2017	BUY	$55.23 - $63.74 $55,230 - $63,740	1,000	1,000 $64,000

Others Institutions Holding BMY

# of Institutions

2,681

Shares Held

1.58B

Call Options Held

28M

Put Options Held

28.4M

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $99.5B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Arcadia Investment Management Corp, based on Form 13F filings with the SEC.

News

Stay updated on Arcadia Investment Management Corp with notifications on news.

Account

Arcadia Investment Management Corp Bristol Myers Squibb CO Transaction History